Discontinuation report GALLIUM

Last updated on 2023-01-20 History
Report ID 161428
Drug Identification Number Not Applicable/non applicable
Brand name GALLIUM
Common or Proper name Gallium Citrate Ga-67 Injection
Company Name LANTHEUS MI CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) GALLIUM CITRATE GA 67
Strength(s) 74MBq
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 mL vial
ATC code V09HX
ATC description
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-12-31
Actual discontinuation date 2022-09-29
Remaining supply date 2022-09-29
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Production issues have determined that it is no longer possible to continue operations. There is no remaining supply.
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600
MONTREAL, QUEBEC
CANADA H4M 2X6
Company contact information lmicanada@lantheus.com 1-800-811-5500

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-01-20 English Compare
v6 2022-10-11 English Compare
v5 2022-10-03 French Compare
v4 2022-10-03 French Compare
v3 2022-10-03 English Compare
v2 2022-05-27 French Compare
v1 2022-05-27 English Compare

Showing 1 to 7 of 7